EUVIMEDEUVIMED entdecken
Crossref

Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy

Masafumi Iguchi, Shigeki Yagyu, Kosuke Kambe, Mayumi Higashi, Shigehisa Fumino, Tsunao Kishida, Tomoko Iehara, Osam Mazda, Tatsuro Tajiri

Anticancer Research · 2023

DOI: 10.21873/anticanres.16409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Masafumi Iguchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan; micloud@koto.kpu-m.ac.jp. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Mesenchymal Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalMesenchymal Stem CellsMiceHumansAnimalsKiller Cells, NaturalAntibody-Dependent Cell CytotoxicityImmunotherapyGangliosides

Stichwörter der Autor:innen

Anti-GD2-antibodydrug deliveryimmunotherapymesenchymal stem cellneuroblastoma

Substanzen

Antibodies, MonoclonalGangliosides

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan; micloud@koto.kpu-m.ac.jp.
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Pediatric Surgery, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Zitieren

APA

Iguchi, M., Yagyu, S., Kambe, K., Higashi, M., Fumino, S., Kishida, T., Iehara, T., Mazda, O., & Tajiri, T. (2023). Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy. Anticancer Research. https://doi.org/10.21873/anticanres.16409

Vancouver

Iguchi M, Yagyu S, Kambe K, Higashi M, Fumino S, Kishida T, et al. Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy. Anticancer Research. 2023. doi:10.21873/anticanres.16409

BibTeX
@article{Iguchi2023,
  author = {Iguchi, Masafumi and Yagyu, Shigeki and Kambe, Kosuke and Higashi, Mayumi and Fumino, Shigehisa and Kishida, Tsunao and Iehara, Tomoko and Mazda, Osam and Tajiri, Tatsuro},
  title = {Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16409}
}
Kostenlos starten →